Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jem Ninan

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Best Practice & Research. Clinical Rheumatology|July 17, 2016
Giant cell arteritisJem Ninan, Susan Lester, Catherine Hill
Clinical & Experimental Ophthalmology|January 11, 2021
Diagnosis and management of giant cell arteritis: Major reviewSumu Simon, Jem Ninan, Pravin Hissaria
BMJ Case Reports|July 22, 2024
Recurrent steroid-responsive polyserositis of unclear aetiology: a possible post-COVID-19 phenomenonPeter Rossi, Michael Wilkinson, Jamie Choong, et al.
Indian Journal of Medical Sciences|September 30, 2003
Spectrum of acute viral hepatitis and its clinical outcome--a study from Ludhiana, PunjabHarjeet Kaur, Mary John, G Pawar, et al.
Internal Medicine Journal|January 5, 2026
Current clinical practice trends in giant cell arteritis diagnosis and management: a national survey of Australian rheumatologists and rheumatology traineesJem Ninan, Jessica Leung, David Liew, et al.
The Journal of Rheumatology|August 17, 2011
Mortality in patients with biopsy-proven giant cell arteritis: a south australian population-based studyJem Ninan, Anh-Minh Nguyen, Antonia Cole, et al.
BMC Rheumatology|May 14, 2025
Influence of socioeconomic status on access to temporal artery biopsy and rates of biopsy positivity in patients with suspected giant cell arteritisSuellen Anne Lyne, Susan Lester, Oscar Kenneth Russell, et al.
Frontiers in Medicine|December 15, 2022
Diagnosis of giant cell arteritis by temporal artery biopsy is associated with biopsy lengthCarlee Ruediger, Jem Ninan, Kathryn Dyer, et al.
BMC Rheumatology|August 9, 2025
Correction: Influence of socioeconomic status on access to temporal artery biopsy and rates of biopsy positivity in patients with suspected giant cell arteritisSuellen Anne Lyne, Susan Lester, Oscar Kenneth Russell, et al.
Frontiers in Medicine|October 14, 2021
Real-Life Retention Rates and Reasons for Switching of Biological DMARDs in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing SpondylitisVandana Bhushan, Susan Lester, Liz Briggs, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Best Practice & Research. Clinical Rheumatology|July 17, 2016
Giant cell arteritisJem Ninan, Susan Lester, Catherine Hill
Clinical & Experimental Ophthalmology|January 11, 2021
Diagnosis and management of giant cell arteritis: Major reviewSumu Simon, Jem Ninan, Pravin Hissaria
BMJ Case Reports|July 22, 2024
Recurrent steroid-responsive polyserositis of unclear aetiology: a possible post-COVID-19 phenomenonPeter Rossi, Michael Wilkinson, Jamie Choong, et al.
Indian Journal of Medical Sciences|September 30, 2003
Spectrum of acute viral hepatitis and its clinical outcome--a study from Ludhiana, PunjabHarjeet Kaur, Mary John, G Pawar, et al.
Internal Medicine Journal|January 5, 2026
Current clinical practice trends in giant cell arteritis diagnosis and management: a national survey of Australian rheumatologists and rheumatology traineesJem Ninan, Jessica Leung, David Liew, et al.
The Journal of Rheumatology|August 17, 2011
Mortality in patients with biopsy-proven giant cell arteritis: a south australian population-based studyJem Ninan, Anh-Minh Nguyen, Antonia Cole, et al.
BMC Rheumatology|May 14, 2025
Influence of socioeconomic status on access to temporal artery biopsy and rates of biopsy positivity in patients with suspected giant cell arteritisSuellen Anne Lyne, Susan Lester, Oscar Kenneth Russell, et al.
Frontiers in Medicine|December 15, 2022
Diagnosis of giant cell arteritis by temporal artery biopsy is associated with biopsy lengthCarlee Ruediger, Jem Ninan, Kathryn Dyer, et al.
BMC Rheumatology|August 9, 2025
Correction: Influence of socioeconomic status on access to temporal artery biopsy and rates of biopsy positivity in patients with suspected giant cell arteritisSuellen Anne Lyne, Susan Lester, Oscar Kenneth Russell, et al.
Frontiers in Medicine|October 14, 2021
Real-Life Retention Rates and Reasons for Switching of Biological DMARDs in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing SpondylitisVandana Bhushan, Susan Lester, Liz Briggs, et al.
Pageof 2